OPO Encyclopedia

Independent Accountability Tracker

industryFebruary 28, 2026· Nasdaq / Google News

TransMedics Stock: A High-Tech Organ Transplant Moonshot?


TransMedics, the maker of the Organ Care System (OCS) for ex-vivo organ perfusion, is attracting investor attention as a high-growth play in transplant technology. The company's portable perfusion devices are expanding the geographic reach of organ procurement by keeping organs viable during longer transport times — a direct impact on OPO logistics and donor utilization rates.

Topics

transmedicsmachine perfusionorgan care systeminvestmenttechnology
Read original source

Opens Nasdaq / Google News in a new tab

The Organ Gap

Weekly intelligence for OPO professionals. Regulatory updates, research breakthroughs, and industry accountability — in your inbox every Tuesday.